HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiko Hoshijima Selected Research

cysteine and glycine-rich protein 3

1/2007Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein.
8/2005Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy.
5/2004Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.
1/2002Muscle LIM protein in heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiko Hoshijima Research Topics

Disease

13Heart Failure
01/2012 - 01/2002
7Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/2013 - 08/2002
4Cardiomegaly (Heart Hypertrophy)
01/2018 - 02/2005
4Cardiomyopathies (Cardiomyopathy)
01/2011 - 05/2004
3Infarction (Infarctions)
01/2019 - 03/2004
2Myocardial Infarction
01/2019 - 02/2012
2Hypertrophy
01/2018 - 03/2003
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2015 - 12/2004
2Fibrosis (Cirrhosis)
02/2012 - 01/2006
2Infections
11/2006 - 02/2003
2Ischemia
01/2006 - 11/2004
1Human Influenza (Influenza)
01/2021
1Cytokine Release Syndrome
01/2021
1Bacterial Pneumonia
01/2021
1Septic Shock (Toxic Shock Syndrome)
01/2021
1Neoplasms (Cancer)
10/2020
1Chronic Obstructive Pulmonary Disease (COPD)
10/2020
1Dyspnea (Shortness of Breath)
10/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2020
1Death (Near-Death Experience)
10/2020
1Idiopathic Interstitial Pneumonias
10/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2020
1Adult-Onset Still's Disease
01/2020
1Macrophage Activation Syndrome
01/2020
1Reperfusion Injury
01/2019
1Sudden Death
01/2018
1Ventricular Tachycardia
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2015
1Heart Diseases (Heart Disease)
09/2015
1Glaucoma
05/2015
1Parkinson Disease (Parkinson's Disease)
12/2014
1Coronary Occlusion
02/2012
1Ventricular Remodeling
01/2012
1Respiratory Insufficiency (Respiratory Failure)
01/2011
1Hypertension (High Blood Pressure)
10/2010
1Virus Diseases (Viral Diseases)
11/2006
1Hypoxia (Hypoxemia)
01/2006
1Wounds and Injuries (Trauma)
03/2005

Drug/Important Bio-Agent (IBA)

6CalciumIBA
09/2015 - 05/2003
5CytokinesIBA
01/2021 - 11/2004
5Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2004
5phospholambanIBA
01/2011 - 08/2002
4cysteine and glycine-rich protein 3IBA
01/2007 - 01/2002
2junctophilinIBA
10/2015 - 12/2004
2CatecholaminesIBA
10/2010 - 05/2004
2Adrenergic Agents (Adrenergic Drugs)IBA
10/2010 - 05/2004
2Peptides (Polypeptides)IBA
07/2007 - 03/2004
2Antiviral Agents (Antivirals)IBA
11/2006 - 02/2003
1SuperantigensIBA
01/2021
1VancomycinFDA LinkGeneric
01/2021
1ExotoxinsIBA
01/2021
1Meropenem (Merrem)FDA LinkGeneric
01/2021
1Clindamycin (Cleocin)FDA LinkGeneric
01/2021
1Morphine (MS Contin)FDA LinkGeneric
10/2020
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2020
1Phosphatidylcholines (Phosphatidylcholine)IBA
01/2019
1Single-Chain AntibodiesIBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2019
11-penicillamyl-Leu(2)- oxytocinIBA
01/2019
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2018
1Glutamic Acid (Glutamate)FDA Link
05/2015
1Dynamins (Dynamin)IBA
12/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2014
1VinculinIBA
04/2013
1AntioxidantsIBA
02/2012
1triphenyltetrazoliumIBA
02/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2012
1Janus KinasesIBA
02/2012
1Small Interfering RNA (siRNA)IBA
01/2012
1Protein Phosphatase 1IBA
01/2012
1Sarcoglycans (beta Sarcoglycan)IBA
01/2011
1Chromogranin AIBA
10/2010
1Protein Isoforms (Isoforms)IBA
06/2010
1InterferonsIBA
11/2006
1DystrophinIBA
11/2006
1IntegrinsIBA
01/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006
1Laminin (Merosin)IBA
01/2006
1Pharmaceutical PreparationsIBA
03/2005
1Cytokine Receptor gp130IBA
02/2005
1Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)IBA
02/2005
1GTP-Binding Proteins (G-Protein)IBA
02/2005
1Caveolin 3IBA
12/2004
12,2,2',4'-tetrachloroacetophenoneIBA
12/2004
1Interleukin-6 (Interleukin 6)IBA
11/2004
1Digitalis GlycosidesIBA
05/2004
1vesnarinoneIBA
05/2004
1Milrinone (Primacor)FDA LinkGeneric
05/2004
1Phosphodiesterase InhibitorsIBA
05/2004
1UrocortinsIBA
03/2004
1Elastomers (Elastomer)IBA
03/2003

Therapy/Procedure

7Therapeutics
10/2020 - 08/2002
1Cannula
10/2020
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
10/2020
1Subcutaneous Infusions
10/2020
1Drug Therapy (Chemotherapy)
01/2008
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2007
1Intravenous Administration
05/2004